BRENTON HALLDEN: Open Payments
NPI 1992351290 · LEWISPORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 96 payments from 20 companies in 2025. Trend: 2023 $844 · 2024 $1,556 · 2025 $1,859
Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $436 |
| ABBVIE INC. | 22 | $298 |
| AstraZeneca Pharmaceuticals LP | 5 | $291 |
| Novo Nordisk Inc | 12 | $182 |
| Corium, LLC | 7 | $131 |
| Axsome Therapeutics, Inc. | 6 | $110 |
| Ardelyx, Inc. | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Amgen Inc. | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
Products named: CAPLYTA, BREZTRI, VRAYLAR, Azstarys, UBRELVY, Ozempic, FARXIGA, Auvelity.
Industry payments across KY — which companies pay providers there.
